Literature DB >> 10194090

Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting.

M K Park1, D R Hospenthal, J E Bennett.   

Abstract

Hydrocephalus can be associated with increased morbidity and mortality in cryptococcal meningitis if left untreated. Both ventriculoperitoneal and ventriculoatrial shunting have been used in persons with cryptococcosis complicated by hydrocephalus, but the indications for and complications, success, and timing of these interventions are not well known. To this end, we reviewed the clinical courses of 10 non-human immunodeficiency virus-infected patients with hydrocephalus secondary to cryptococcal meningitis who underwent shunting procedures. Nine of 10 patients who underwent shunting had noticeable improvement in dementia and gait. Two patients required late revision of their shunts. Shunt placement in eight patients with acute infection did not disseminate cryptococcal infection into the peritoneum or bloodstream, nor did shunting provide a nidus from which Cryptococcus organisms proved difficult to eradicate. Shunting procedures are a safe and effective therapy for hydrocephalus in patients with cryptococcal meningitis and need not be delayed until patients are mycologically cured.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194090     DOI: 10.1086/515161

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Management of cryptococcal meningitis in sub-saharan Africa.

Authors:  Arthur Jackson; Mina C Hosseinipour
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

2.  Therapy of Cryptococcal Meningitis in non-HIV-infected Patients.

Authors:  Peter G. Pappas
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

Review 3.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

6.  Cryptococcal Meningitis.

Authors:  Lourdes Irizarry
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

7.  Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.

Authors:  Gautam U Mehta; Anil A Panackal; Roger Murayi; John E Bennett; Peter R Williamson; Prashant Chittiboina
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-26       Impact factor: 10.154

Review 8.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Management of Increased Intracranial Pressure in Cryptococcal Meningitis.

Authors:  Kimberly J. Gambarin; Richard J. Hamill
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

10.  Cryptococcal meningitis manifesting as a large abdominal cyst in a HIV-infected patient with a CD4 count greater than 400 cells/mm(3).

Authors:  Nancy Crum-Cianflone; April Truett; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2008-05       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.